Cytheris is a product-oriented biopharmaceutical company focused on the research and international development of new and critical agents for immune modulation. These drugs aim at reconstituting, enhancing or modulating the immune system activity of patients suffering from life-threatening diseases including Bone Marrow Transplants, HIV/AIDS and Cancer.